Cytosorbents Corp 8-K

What Happened

• On May 13, 2026, CytoSorbents Corporation (CTSO) filed a Form 8-K (Item 2.02) to announce its financial results for the quarter ended March 31, 2026.
• The company furnished a press release dated May 13, 2026 as Exhibit 99.1 to the filing; the Cover Page Interactive Data File (Inline XBRL) is included as Exhibit 104.

Key Details

• Filing date: May 13, 2026.
• Period reported: Quarter ended March 31, 2026 (Q1 2026).
• Press release attached as Exhibit 99.1 (dated May 13, 2026).
• The Item 2.02 information is furnished, not “filed,” and is therefore not subject to Section 18 liability or automatic incorporation by reference in other filings.

Why It Matters

• This Form 8-K signals CytoSorbents’ public release of its quarterly earnings and other financial metrics for Q1 2026; investors should review the attached press release (Exhibit 99.1) for revenue, profit/loss, guidance or operational updates.
• Because the filing furnishes — rather than files — the results under Item 2.02, the company includes the standard legal disclaimer about Section 18 and incorporation by reference; the substantive financial details are in the press release itself.